Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012, Article ID 634914, 8 pages
http://dx.doi.org/10.1155/2012/634914
Research Article

Stimulation of Cultured H9 Human Embryonic Stem Cells with Thyroid Stimulating Hormone Does Not Lead to Formation of Thyroid-Like Cells

1Imaging Sciences Training Program, Clinical Center and National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
2Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA

Received 2 November 2011; Accepted 31 December 2011

Academic Editor: Gerald A. Colvin

Copyright © 2012 Mykola I. Onyshchenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Liew, H. Moore, L. Ruban et al., “Human embryonic stem cells: possibilities for human cell transplantation,” Annals of Medicine, vol. 37, no. 7, pp. 521–532, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. T. Scott, J. B. McCormick, M. C. Derouen, and J. Owen-Smith, “Federal policy and the use of pluripotent stem cells,” Nature Methods, vol. 7, no. 11, pp. 866–867, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. Chester and R. Sackstein, “Embryonic stem cell-based therapeutics: balancing scientific progress and bioethics,” Health Matrix, vol. 20, no. 1, pp. 203–217, 2010. View at Google Scholar · View at Scopus
  4. R. Y. Lin and T. F. Davies, “Differentiating thyroid cells,” Thyroid, vol. 20, no. 1, pp. 1–2, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. M. C. Arufe, M. Lu, A. Kubo, G. Keller, T. F. Davies, and R. Y. Lin, “Directed differentiation of mouse embryonic stem cells into thyroid follicular cells,” Endocrinology, vol. 147, no. 6, pp. 3007–3015, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. C. Arufe, M. Lu, and R. Y. Lin, “Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1,” Biochemical and Biophysical Research Communications, vol. 381, no. 2, pp. 264–270, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. I. Ginis, Y. Luo, T. Miura et al., “Differences between human and mouse embryonic stem cells,” Developmental Biology, vol. 269, no. 2, pp. 360–380, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. A. D'Amour, A. D. Agulnick, S. Eliazer, O. G. Kelly, E. Kroon, and E. E. Baetge, “Efficient differentiation of human embryonic stem cells to definitive endoderm,” Nature Biotechnology, vol. 23, no. 12, pp. 1534–1541, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. B. McLean, K. A. D'Amour, K. L. Jones et al., “Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed,” Stem Cells, vol. 25, no. 1, pp. 29–38, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. I. Presta, F. Arturi, E. Ferretti et al., “Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene,” BMC Cancer, vol. 5, article no. 80, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. M. Karp, L. S. Ferreira, A. Khademhosseini, A. H. Kwon, J. Yeh, and R. S. Langer, “Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro,” Stem Cells, vol. 24, no. 4, pp. 835–843, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. Kurosawa, “Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells,” Journal of Bioscience and Bioengineering, vol. 103, no. 5, pp. 389–398, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. B. Bhattacharya, S. Puri, and R. K. Puri, “A review of gene expression profiling of human embryonic stem cell lines and their differentiated progeny,” Current Stem Cell Research and Therapy, vol. 4, no. 2, pp. 98–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Bratt-Leal, R. L. Carpenedo, and T. C. McDevitt, “Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation,” Biotechnology Progress, vol. 25, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Penna-Martinez, C. Winten, T. Fichtel, G. Caspar-Bell, K. H. Usadel, and P. M. Schumm-Draeger, “Isolation of thyroid cells obtained by fine-needle aspiration biopsy,” Thyroid, vol. 15, no. 9, pp. 989–995, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. O. Dohán, A. De La Vieja, V. Paroder et al., “The sodium/iodide symporter (NIS): characterization, regulation, and medical significance,” Endocrine Reviews, vol. 24, no. 1, pp. 48–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Baker and J. C. Morris, “The sodium-iodide symporter,” Current Drug Targets: Immune, Endocrine and Metabolic Disorders, vol. 4, no. 3, pp. 167–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Foujilas, C. Marakaki, and N. Sirmos, “Sodium-iodine symporter in thyroid, normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment,” Hellenic Journal of Nuclear Medicine, vol. 12, no. 2, pp. 189–193, 2009. View at Google Scholar · View at Scopus
  19. T. Kogai, K. Taki, and G. A. Brent, “Enhancement of sodium/iodide symporter expression in thyroid and breast cancer,” Endocrine-Related Cancer, vol. 13, no. 3, pp. 797–826, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. Ryan, C. E. Curran, E. Hennessy et al., “The sodium iodide Symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue,” PLoS One, vol. 6, no. 1, article e16023, 2011. View at Publisher · View at Google Scholar · View at PubMed
  21. S. Beyer, A. Lakshmanan, Y. Y. Liu et al., “KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells,” Endocrinology, vol. 152, no. 3, pp. 782–792, 2011. View at Publisher · View at Google Scholar · View at PubMed
  22. S. Unterholzner, M. J. Willhauck, N. Cengic et al., “Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 1, pp. 69–78, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Sponziello, A. Scipioni, C. Durante et al., “Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines,” Journal of Endocrinological Investigation, vol. 33, no. 1, pp. 2–6, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. I. V. Scholz, N. Cengic, C. H. Baker et al., “Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer,” Gene Therapy, vol. 12, no. 3, pp. 272–280, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. C. Spitzweg, C. H. Baker, E. R. Bergert, M. K. O'Connor, and J. C. Morris, “Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression,” Human Gene Therapy, vol. 18, no. 10, pp. 916–924, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. N. Cengic, C. H. Baker, M. Schütz, B. Göke, J. C. Morris, and C. Spitzweg, “A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4457–4464, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. P. M. Schumm-Draeger, “Sodium/iodide symporter (NIS) and cytokines,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, no. 1, pp. 32–34, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. T. Touboul, N. R.F. Hannan, S. Corbineau et al., “Generation of functionalhepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development,” Hepatology, vol. 52, no. 1, p. 402, 2010. View at Publisher · View at Google Scholar
  29. T. Touboul, N. R.F. Hannan, S. Corbineau et al., “Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development,” Hepatology, vol. 51, no. 5, pp. 1754–1765, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. J. Ameri, A. Stahlberg, J. Pedersen et al., “FGF2 specifies hESC-derived definitive endoderm into foregut/midgut cell lineages in a concentration-dependent manner,” Stem Cells, vol. 28, no. 1, pp. 45–56, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. N. Shiraki, T. Yoshida, K. Araki et al., “Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm,” Stem Cells, vol. 26, no. 4, pp. 874–885, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. O. Adewumi, B. Aflatoonian, L. Ahrlund-Richter et al., “Characterization of human embryonic stem cell lines by the international stem cell initiative,” Nature Biotechnology, vol. 25, no. 7, pp. 803–816, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus